Cite
HARVARD Citation
Nash, P. et al. (n.d.). AB0943 Sustained improvements with up to 104 weeks of apremilast monotherapy in biologic-naÏve subjects with active psoriatic arthritis: results from a phase 3b, randomised, controlled trial. Annals of the rheumatic diseases. p. 1596. [Online].